June 2026 FDA Recall Methylergonovine Maleate by The Harvard Drug Group Llc
D-0609-2026 - Subpotent Drug

This Class II drug recall was voluntarily initiated by The Harvard Drug Group Llc on June 16, 2026 for the product Methylergonovine Maleate. The FDA reported the reason for recall as subpotent drug. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0609-2026

Reason for Recall
Subpotent Drug
Initiated
06-16-2026
Reported
07-01-2026
Quantity
790 Cartons.

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
The Harvard Drug Group LLC
Carton Label: MAJOR, Methylergonovine Maleate Tablets, USP, 0.2 mg, 20 TABLETS (2 x 10), Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, in 46268, NDC 0904-7282-10. Blister Label: Methylergonovine Maleate Tablets, 0.2 mg, USP, One Tablet, Major Pharm/Indianapolis, IN 46268, NDC 0904-7282-10.

Batch or Lot Expiration Information

Lot# Lots: N02327, expires: 09/2026; N02740, expires: 12/2026; N03069, expires: 08/2027.

Affected Packages Involved in this Recall